4
Changes in Ownership
Sionna Therapeutics, Inc. Filed Acc 0001451612-25-000008
Director sold 194,932 shares at an average $30.47 ($5,939,784)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Booth Bruce Director | 2025-10-10 | Sale 10b5-1 | −16,727 | $29.98 | $501,475 | 2,763,574 | I: show line 1 in the form |
| Booth Bruce Director | 2025-10-10 | Sale 10b5-1 | −3,511 | $29.98 | $105,260 | 781,969 | I: show line 2 in the form |
| Booth Bruce Director | 2025-10-13 | Sale 10b5-1 | −44,048 | $30.32 | $1,335,535 | 2,719,526 | I: show line 3 in the form |
| Booth Bruce Director | 2025-10-13 | Sale 10b5-1 | −9,245 | $30.32 | $280,308 | 772,724 | I: show line 4 in the form |
| Booth Bruce Director | 2025-10-13 | Sale 10b5-1 | −4,082 | $31.03 | $126,664 | 2,715,444 | I: show line 5 in the form |
| Booth Bruce Director | 2025-10-13 | Sale 10b5-1 | −857 | $31.03 | $26,593 | 771,867 | I: show line 6 in the form |
| Booth Bruce Director | 2025-10-14 | Sale 10b5-1 | −501 | $29.95 | $15,005 | 2,714,943 | I: show line 7 in the form |
| Booth Bruce Director | 2025-10-14 | Sale 10b5-1 | −105 | $29.95 | $3,145 | 771,762 | I: show line 8 in the form |
| Open-market sales · 194,932 sh · avg $30.47 · $5,939,784 | |||||||
Loading xslF345X05/form4-10152025_101022.xml…